CSF2 and intrahepatic cholangiocarcinoma: While no relationship between these biomarkers and RFS or OS was evident in ICC patients (Supplementary Fig. 6A–F), there was a trend (p = 0.051) towards higher GM-CSF and worse RFS in ECC patients (Fig. 4e).